Psychedelic drugs tend to have a bad reputation; they can have harmful effects and lead to addiction. Many countries regulate them heavily. Now, however, researchers ask whether such substances may be used to manage conditions such as anxiety.
The annual convention of the American Psychological Association (APA) — held this year in San Francisco, CA — is home to much thought-provoking debate about which directions psychotherapy should next consider.
This year, researchers from various global institutions discussed the potential of psychedelic drugs in the management of anxiety, depression, and psychological trauma symptoms.
Full story at Medical News Today
In a new study published in the Journal of Psychopharmacology, researchers from UBC’s Okanagan campus have discovered that men who have used psychedelic drugs in the past have a lower likelihood of engaging in violence against their intimate partners.
“Although use of certain drugs like alcohol, methamphetamine or cocaine is associated with increased aggression and partner violence, use of psychedelics appears to have the opposite effect,” says clinical psychology graduate student and study lead author Michelle Thiessen. “We found that among men who have used psychedelics one or more times, the odds of engaging in partner violence was reduced by roughly half. That’s significant.”
Full story at Science Daily
An adult psychiatry expert in the U.K. is calling for psychedelic drugs to be re-examined for their potential benefits for people with psychiatric disorders.
Dr. James Rucker of King’s College London, U.K., believes that psychedelic drugs such as lysergic acid diethylamide (LSD) “should be legally reclassified so that researchers can investigate their therapeutic potential.”
In the United States, LSD is a schedule I controlled substance under the Controlled Substances Act. This means that the federal government believes LSD to have high abuse potential, a lack of accepted safe use when taken under medical supervision, and no current medical use.
Full story of growing use of psychedelic drugs at Psych Central